Adage Capital Partners Gp, L.L.C. Jazz Pharmaceuticals PLC Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $77.3 Million - $98.4 Million	-610,740 Reduced 84.24%	114,260 $15.2 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $10.6 Million - $12.6 Million	75,000 Added 11.54%	725,000 $113 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $13 Million - $16.1 Million	-100,000 Reduced 13.33%	650,000 $101 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $29.1 Million - $35.3 Million	242,606 Added 47.81%	750,000 $95.6 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $25.7 Million - $37 Million	200,000 Added 65.06%	507,394 $66.1 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $46.9 Million - $54.5 Million	-292,606 Reduced 48.77%	307,394 $54.6 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $42.8 Million - $49.4 Million	285,000 Added 90.48%	600,000 $98.6 Million
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $12.7 Million - $14.9 Million	90,000 Added 40.0%	315,000 $52 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $21.5 Million - $27.4 Million	225,000 New	225,000 $24.8 Million
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $31.1 Million - $34.9 Million	-193,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $22.9 Million - $28.6 Million	-156,189 Reduced 44.73%	193,000 $33.3 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $16.2 Million - $18.7 Million	-119,186 Reduced 25.45%	349,189 $52.7 Million
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $18.8 Million - $21.6 Million	143,375 Added 44.12%	468,375 $63.1 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $46.4 Million - $50.6 Million	325,000	325,000 $47.5 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account